Citation Impact
Citing Papers
Role of UEV-1, an Inactive Variant of the E2 UbiquitinConjugating Enzymes, in In Vitro Differentiation and Cell Cycle Behavior of HT-29-M6 Intestinal Mucosecretory Cells
1998 StandoutNobel
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers
2013 Standout
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Discovery of Activation‐Induced Cytidine Deaminase, the Engraver of Antibody Memory
2007 StandoutNobel
Guidelines for the welfare and use of animals in cancer research
2010 Standout
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 Standout
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
EGFR Antagonists in Cancer Treatment
2008 Standout
Viral protein R regulates nuclear import of the HIV-1 pre-integration complex
1998
Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
2011 Standout
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Bronchioloalveolar Carcinoma: The Case for Two Diseases
2008
HIV-1 nuclear import in search of a leader
1997
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Bronchioloalveolar Lung Cancer
2007
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity
2019
Lung Cancer
2008 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol
2015
Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex
1998 StandoutNobel
Grade of Stromal Invasion in Small Adenocarcinoma of the Lung
2004
Oncolytic viruses
2002
HIV accessory proteins as therapeutic targets
1997
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Histologic features are important prognostic indicators in early stages lung adenocarcinomas
2006
A Correlation between EGFR Gene Mutation Status and Bronchioloalveolar Carcinoma Features in Japanese Patients with Adenocarcinoma
2006
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
2000 StandoutNobel
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer
2015
Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors
2006
Mitochondrial membrane permeabilization by HIV-1 Vpr
2004
HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
1998
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Requirement of Non-canonical Activity of Uracil DNA Glycosylase for Class Switch Recombination
2006 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Do Vpu and Vpr of Human Immunodeficiency Virus Type 1 and NB of Influenza B Virus Have Ion Channel Activities in the Viral Life Cycles?
1997
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
Oxidative Stress in Cancer
2020 Standout
Worldwide trends in lung cancer pathology
2006
Interaction between the HIV‐1 Protein Vpr and the Adenine Nucleotide Translocator
2006
Programmed Cell Death as a Mechanism of CD4 and CD8 T Cell Deletion in AIDS: Molecular Control and Effect of Highly Active Anti‐retroviral Therapy
1999 StandoutNobel
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
1997 Standout
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
‘Targeting’ the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa®) in non-small cell lung cancer (NSCLC)
2004
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Gender-Associated Differences in Lung Cancer: Clinical Characteristics and Treatment Outcomes in Women
2009
Subsolid pulmonary nodules: CT–pathologic correlation using the 2011 IASLC/ATS/ERS classification
2014
Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses
2005
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Role of viral regulatory and accessory proteins in HIV-1 replication
2004
Nuclear Import and Export of Viruses and Virus Genomes
1998
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Special Treatment Issues in Non-small Cell Lung Cancer
2013
A unified classification system for eukaryotic transposable elements
2007 Standout
Characterization of HIV-1 Vpr Nuclear Import: Analysis of Signals and Pathways
1998
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
2004
Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest
1997
Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules
2013
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Vpr Stimulates Viral Expression and Induces Cell Killing in Human Immunodeficiency Virus Type 1-Infected Dividing Jurkat T Cells
1998
Epidemiology of Bronchioloalveolar Carcinoma: Improvement in Survival After Release of the 1999 WHO Classification of Lung Tumors
2005
Genetics of Plant Virus Resistance
2005 Standout
Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer
2005
Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
2006
The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate
2000
Amplification of a Complete Simian Immunodeficiency Virus Genome from Fecal RNA of a Wild Chimpanzee
2003
Interaction of the Human Immunodeficiency Virus Type 1 Vpr Protein with the Nuclear Pore Complex
1998
HIV-1 nuclear import: in search of a leader; update 1999
1999
Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.
1996 StandoutNobel
Transport Between the Cell Nucleus and the Cytoplasm
1999 Standout
Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers
2005
Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import
1996
HIV-1 Nuclear Import: Matrix Protein Is Back on Center Stage, This Time Together with Vpr
1998
Current Concepts in Bronchioloalveolar Carcinoma Biology
2006
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle
2000
HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection
2002
Simian Immunodeficiency Virus Infection in Wild-Caught Chimpanzees from Cameroon
2004 StandoutNobel
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
1997
The Amino-Terminal Region of Vpr from Human Immunodeficiency Virus Type 1 Forms Ion Channels and Kills Neurons
1999
Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma
2015
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
1995
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Works of Michael I. Ebright being referenced
Epidermal Growth Factor Receptor Signaling in Adenocarcinomas With Bronchioloalveolar Components
2007
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma
2002
Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection
2003
Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non–small cell lung cancer
2013
SCCRO Expression Correlates With Invasive Progression in Bronchioloalveolar Carcinoma
2004
Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model
2002
Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues
2013
Evaluation of the Caprini Model for Venothromboembolism in Esophagectomy Patients
2015
Sublobar Versus Lobar Resection
2011
Combination Vascular Delivery of Herpes Simplex Oncolytic Viruses and Amplicon Mediated Cytokine Gene Transfer Is Effective Therapy for Experimental Liver Cancer
2001
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
1995